code stringlengths 4 12 | description stringlengths 2 264 | codetype stringclasses 8
values | context stringlengths 160 15.5k |
|---|---|---|---|
M0300 | Iv chelationtherapy | HCPCS | Most of these interventions have not been proven efficacious in blinded randomized controlled trials”. An UpToDate review on “Attention deficit hyperactivity disorder in children and adolescents: Treatment with medications” (Krull, 2015b) does not mention bupropion, reboxetine, desipramine and nortriptyline as therapeu... |
98941 | PR CHIROPRACTIC MANIPULATIVE TX SPINAL 3-4 REGIONS | HCPCS | Most of these interventions have not been proven efficacious in blinded randomized controlled trials”. An UpToDate review on “Attention deficit hyperactivity disorder in children and adolescents: Treatment with medications” (Krull, 2015b) does not mention bupropion, reboxetine, desipramine and nortriptyline as therapeu... |
S8040 | TOPOGRAPHIC BRAIN MAPPING | HCPCS | Most of these interventions have not been proven efficacious in blinded randomized controlled trials”. An UpToDate review on “Attention deficit hyperactivity disorder in children and adolescents: Treatment with medications” (Krull, 2015b) does not mention bupropion, reboxetine, desipramine and nortriptyline as therapeu... |
90833 | Psytx w pt w e/m 30 min | HCPCS | Most of these interventions have not been proven efficacious in blinded randomized controlled trials”. An UpToDate review on “Attention deficit hyperactivity disorder in children and adolescents: Treatment with medications” (Krull, 2015b) does not mention bupropion, reboxetine, desipramine and nortriptyline as therapeu... |
92537 | PR CALORIC VESTIBULAR TEST W/REC BI BITHERMAL | HCPCS | Most of these interventions have not been proven efficacious in blinded randomized controlled trials”. An UpToDate review on “Attention deficit hyperactivity disorder in children and adolescents: Treatment with medications” (Krull, 2015b) does not mention bupropion, reboxetine, desipramine and nortriptyline as therapeu... |
0359T | Behavioral id assessment | HCPCS | Most of these interventions have not been proven efficacious in blinded randomized controlled trials”. An UpToDate review on “Attention deficit hyperactivity disorder in children and adolescents: Treatment with medications” (Krull, 2015b) does not mention bupropion, reboxetine, desipramine and nortriptyline as therapeu... |
78608 | HC BRAIN (CNS) TUMOR LOCALIZATION | HCPCS | Most of these interventions have not been proven efficacious in blinded randomized controlled trials”. An UpToDate review on “Attention deficit hyperactivity disorder in children and adolescents: Treatment with medications” (Krull, 2015b) does not mention bupropion, reboxetine, desipramine and nortriptyline as therapeu... |
96152 | Intervene hlth/behave indiv | HCPCS | Most of these interventions have not been proven efficacious in blinded randomized controlled trials”. An UpToDate review on “Attention deficit hyperactivity disorder in children and adolescents: Treatment with medications” (Krull, 2015b) does not mention bupropion, reboxetine, desipramine and nortriptyline as therapeu... |
70546 | MRI scan of blood vessels of head before and after contrast | HCPCS | Most of these interventions have not been proven efficacious in blinded randomized controlled trials”. An UpToDate review on “Attention deficit hyperactivity disorder in children and adolescents: Treatment with medications” (Krull, 2015b) does not mention bupropion, reboxetine, desipramine and nortriptyline as therapeu... |
95813 | PR EEG EXTENDED MONITORING 61-119 MINUTES | HCPCS | Most of these interventions have not been proven efficacious in blinded randomized controlled trials”. An UpToDate review on “Attention deficit hyperactivity disorder in children and adolescents: Treatment with medications” (Krull, 2015b) does not mention bupropion, reboxetine, desipramine and nortriptyline as therapeu... |
86001 | Measurement of antibody (IgG) to allergic substance, each allergen | HCPCS | Most of these interventions have not been proven efficacious in blinded randomized controlled trials”. An UpToDate review on “Attention deficit hyperactivity disorder in children and adolescents: Treatment with medications” (Krull, 2015b) does not mention bupropion, reboxetine, desipramine and nortriptyline as therapeu... |
96116 | PR NEUROBEHAVIORAL STATUS XM PHYS/QHP 1ST HOUR | HCPCS | Most of these interventions have not been proven efficacious in blinded randomized controlled trials”. An UpToDate review on “Attention deficit hyperactivity disorder in children and adolescents: Treatment with medications” (Krull, 2015b) does not mention bupropion, reboxetine, desipramine and nortriptyline as therapeu... |
96127 | PR BEHAV ASSMT W/SCORE & DOCD/STAND INSTRUMENT | HCPCS | Most of these interventions have not been proven efficacious in blinded randomized controlled trials”. An UpToDate review on “Attention deficit hyperactivity disorder in children and adolescents: Treatment with medications” (Krull, 2015b) does not mention bupropion, reboxetine, desipramine and nortriptyline as therapeu... |
92545 | PR OSCILLATING TRACKING TEST W/RECORDING | HCPCS | Most of these interventions have not been proven efficacious in blinded randomized controlled trials”. An UpToDate review on “Attention deficit hyperactivity disorder in children and adolescents: Treatment with medications” (Krull, 2015b) does not mention bupropion, reboxetine, desipramine and nortriptyline as therapeu... |
96150 | Assess hlth/behave init | HCPCS | Most of these interventions have not been proven efficacious in blinded randomized controlled trials”. An UpToDate review on “Attention deficit hyperactivity disorder in children and adolescents: Treatment with medications” (Krull, 2015b) does not mention bupropion, reboxetine, desipramine and nortriptyline as therapeu... |
82784 | Immunoglobulin M QST | HCPCS | Most of these interventions have not been proven efficacious in blinded randomized controlled trials”. An UpToDate review on “Attention deficit hyperactivity disorder in children and adolescents: Treatment with medications” (Krull, 2015b) does not mention bupropion, reboxetine, desipramine and nortriptyline as therapeu... |
78600 | HC NM BRAIN LESS THAN 4 STATIC VW | HCPCS | Most of these interventions have not been proven efficacious in blinded randomized controlled trials”. An UpToDate review on “Attention deficit hyperactivity disorder in children and adolescents: Treatment with medications” (Krull, 2015b) does not mention bupropion, reboxetine, desipramine and nortriptyline as therapeu... |
78607 | Brain imaging (3d) | HCPCS | Most of these interventions have not been proven efficacious in blinded randomized controlled trials”. An UpToDate review on “Attention deficit hyperactivity disorder in children and adolescents: Treatment with medications” (Krull, 2015b) does not mention bupropion, reboxetine, desipramine and nortriptyline as therapeu... |
92585 | Auditor evoke potent compre | HCPCS | Most of these interventions have not been proven efficacious in blinded randomized controlled trials”. An UpToDate review on “Attention deficit hyperactivity disorder in children and adolescents: Treatment with medications” (Krull, 2015b) does not mention bupropion, reboxetine, desipramine and nortriptyline as therapeu... |
96105 | Test to assess the loss of the ability to speak, write, and understand language | HCPCS | Most of these interventions have not been proven efficacious in blinded randomized controlled trials”. An UpToDate review on “Attention deficit hyperactivity disorder in children and adolescents: Treatment with medications” (Krull, 2015b) does not mention bupropion, reboxetine, desipramine and nortriptyline as therapeu... |
70450 | HC CT HEAD/BRAIN WITHOUT DYE | HCPCS | Most of these interventions have not been proven efficacious in blinded randomized controlled trials”. An UpToDate review on “Attention deficit hyperactivity disorder in children and adolescents: Treatment with medications” (Krull, 2015b) does not mention bupropion, reboxetine, desipramine and nortriptyline as therapeu... |
92550 | Tympanometry & reflex thresh | HCPCS | Most of these interventions have not been proven efficacious in blinded randomized controlled trials”. An UpToDate review on “Attention deficit hyperactivity disorder in children and adolescents: Treatment with medications” (Krull, 2015b) does not mention bupropion, reboxetine, desipramine and nortriptyline as therapeu... |
96365 | PR IV INFUSION THERAPY/PROPHYLAXIS /DX 1ST TO 1 HR | HCPCS | Most of these interventions have not been proven efficacious in blinded randomized controlled trials”. An UpToDate review on “Attention deficit hyperactivity disorder in children and adolescents: Treatment with medications” (Krull, 2015b) does not mention bupropion, reboxetine, desipramine and nortriptyline as therapeu... |
P2031 | HAIR ANALYSIS (EXCLUDING ARSENIC) | HCPCS | Most of these interventions have not been proven efficacious in blinded randomized controlled trials”. An UpToDate review on “Attention deficit hyperactivity disorder in children and adolescents: Treatment with medications” (Krull, 2015b) does not mention bupropion, reboxetine, desipramine and nortriptyline as therapeu... |
0374T | Expose behav treatment addl | CPT | Most of these interventions have not been proven efficacious in blinded randomized controlled trials”. An UpToDate review on “Attention deficit hyperactivity disorder in children and adolescents: Treatment with medications” (Krull, 2015b) does not mention bupropion, reboxetine, desipramine and nortriptyline as therapeu... |
90838 | Psytx w pt w e/m 60 min | HCPCS | Most of these interventions have not been proven efficacious in blinded randomized controlled trials”. An UpToDate review on “Attention deficit hyperactivity disorder in children and adolescents: Treatment with medications” (Krull, 2015b) does not mention bupropion, reboxetine, desipramine and nortriptyline as therapeu... |
H1010 | Nonmed family planning ed | HCPCS | Most of these interventions have not been proven efficacious in blinded randomized controlled trials”. An UpToDate review on “Attention deficit hyperactivity disorder in children and adolescents: Treatment with medications” (Krull, 2015b) does not mention bupropion, reboxetine, desipramine and nortriptyline as therapeu... |
90832 | Psytx w pt 30 minutes | HCPCS | Most of these interventions have not been proven efficacious in blinded randomized controlled trials”. An UpToDate review on “Attention deficit hyperactivity disorder in children and adolescents: Treatment with medications” (Krull, 2015b) does not mention bupropion, reboxetine, desipramine and nortriptyline as therapeu... |
92541 | Spontaneous nystagmus test | HCPCS | Most of these interventions have not been proven efficacious in blinded randomized controlled trials”. An UpToDate review on “Attention deficit hyperactivity disorder in children and adolescents: Treatment with medications” (Krull, 2015b) does not mention bupropion, reboxetine, desipramine and nortriptyline as therapeu... |
G0176 | Opps/php/iop; activity thrpy | HCPCS | Most of these interventions have not been proven efficacious in blinded randomized controlled trials”. An UpToDate review on “Attention deficit hyperactivity disorder in children and adolescents: Treatment with medications” (Krull, 2015b) does not mention bupropion, reboxetine, desipramine and nortriptyline as therapeu... |
T1018 | School-based IEP ser bundled | HCPCS | Most of these interventions have not been proven efficacious in blinded randomized controlled trials”. An UpToDate review on “Attention deficit hyperactivity disorder in children and adolescents: Treatment with medications” (Krull, 2015b) does not mention bupropion, reboxetine, desipramine and nortriptyline as therapeu... |
96154 | Interv hlth/behav fam w/pt | HCPCS | Most of these interventions have not been proven efficacious in blinded randomized controlled trials”. An UpToDate review on “Attention deficit hyperactivity disorder in children and adolescents: Treatment with medications” (Krull, 2015b) does not mention bupropion, reboxetine, desipramine and nortriptyline as therapeu... |
92547 | PR USE VERTICAL ELECTRODES | HCPCS | Most of these interventions have not been proven efficacious in blinded randomized controlled trials”. An UpToDate review on “Attention deficit hyperactivity disorder in children and adolescents: Treatment with medications” (Krull, 2015b) does not mention bupropion, reboxetine, desipramine and nortriptyline as therapeu... |
92065 | PR ORTHOPTIC TRAINING PERFORMED BY PHYS/OTHER QHP | HCPCS | Most of these interventions have not been proven efficacious in blinded randomized controlled trials”. An UpToDate review on “Attention deficit hyperactivity disorder in children and adolescents: Treatment with medications” (Krull, 2015b) does not mention bupropion, reboxetine, desipramine and nortriptyline as therapeu... |
95954 | PR RX/PHYSICAL EEG ACTIVAJ PHYS/QHP ATTENDANCE | HCPCS | Most of these interventions have not been proven efficacious in blinded randomized controlled trials”. An UpToDate review on “Attention deficit hyperactivity disorder in children and adolescents: Treatment with medications” (Krull, 2015b) does not mention bupropion, reboxetine, desipramine and nortriptyline as therapeu... |
S9445 | PT education noc individ | HCPCS | Most of these interventions have not been proven efficacious in blinded randomized controlled trials”. An UpToDate review on “Attention deficit hyperactivity disorder in children and adolescents: Treatment with medications” (Krull, 2015b) does not mention bupropion, reboxetine, desipramine and nortriptyline as therapeu... |
95819 | PR ELECTROENCEPHALOGRAM W/REC AWAKE&ASLEEP | HCPCS | Most of these interventions have not been proven efficacious in blinded randomized controlled trials”. An UpToDate review on “Attention deficit hyperactivity disorder in children and adolescents: Treatment with medications” (Krull, 2015b) does not mention bupropion, reboxetine, desipramine and nortriptyline as therapeu... |
96368 | THER/DIAG CONCURRENT INF | HCPCS | Most of these interventions have not been proven efficacious in blinded randomized controlled trials”. An UpToDate review on “Attention deficit hyperactivity disorder in children and adolescents: Treatment with medications” (Krull, 2015b) does not mention bupropion, reboxetine, desipramine and nortriptyline as therapeu... |
A9585 | Injection, gadobutrol, 0.1 ml | HCPCS | Most of these interventions have not been proven efficacious in blinded randomized controlled trials”. An UpToDate review on “Attention deficit hyperactivity disorder in children and adolescents: Treatment with medications” (Krull, 2015b) does not mention bupropion, reboxetine, desipramine and nortriptyline as therapeu... |
78606 | HC BRAIN IMAGING, MINIMUM 4 STATIC VIEWS; WITH VASCULAR FLOW | HCPCS | Most of these interventions have not been proven efficacious in blinded randomized controlled trials”. An UpToDate review on “Attention deficit hyperactivity disorder in children and adolescents: Treatment with medications” (Krull, 2015b) does not mention bupropion, reboxetine, desipramine and nortriptyline as therapeu... |
92587 | PR DISTORT PRODUCT EVOKED OTOACOUSTIC EMISNS LIMITD | HCPCS | Most of these interventions have not been proven efficacious in blinded randomized controlled trials”. An UpToDate review on “Attention deficit hyperactivity disorder in children and adolescents: Treatment with medications” (Krull, 2015b) does not mention bupropion, reboxetine, desipramine and nortriptyline as therapeu... |
70460 | HC CT HEAD/BRAIN WITH DYE | HCPCS | Most of these interventions have not been proven efficacious in blinded randomized controlled trials”. An UpToDate review on “Attention deficit hyperactivity disorder in children and adolescents: Treatment with medications” (Krull, 2015b) does not mention bupropion, reboxetine, desipramine and nortriptyline as therapeu... |
G0295 | Electromagnetic therapy onc | HCPCS | Most of these interventions have not been proven efficacious in blinded randomized controlled trials”. An UpToDate review on “Attention deficit hyperactivity disorder in children and adolescents: Treatment with medications” (Krull, 2015b) does not mention bupropion, reboxetine, desipramine and nortriptyline as therapeu... |
90791 | PSY DX EVALUATION | HCPCS | Most of these interventions have not been proven efficacious in blinded randomized controlled trials”. An UpToDate review on “Attention deficit hyperactivity disorder in children and adolescents: Treatment with medications” (Krull, 2015b) does not mention bupropion, reboxetine, desipramine and nortriptyline as therapeu... |
96103 | Psycho testing admin by comp | HCPCS | Most of these interventions have not been proven efficacious in blinded randomized controlled trials”. An UpToDate review on “Attention deficit hyperactivity disorder in children and adolescents: Treatment with medications” (Krull, 2015b) does not mention bupropion, reboxetine, desipramine and nortriptyline as therapeu... |
92567 | TYMPANOMETRY | HCPCS | Most of these interventions have not been proven efficacious in blinded randomized controlled trials”. An UpToDate review on “Attention deficit hyperactivity disorder in children and adolescents: Treatment with medications” (Krull, 2015b) does not mention bupropion, reboxetine, desipramine and nortriptyline as therapeu... |
95925 | Somatosensory testing | HCPCS | Most of these interventions have not been proven efficacious in blinded randomized controlled trials”. An UpToDate review on “Attention deficit hyperactivity disorder in children and adolescents: Treatment with medications” (Krull, 2015b) does not mention bupropion, reboxetine, desipramine and nortriptyline as therapeu... |
88318 | Chemical histochemistry | HCPCS | Most of these interventions have not been proven efficacious in blinded randomized controlled trials”. An UpToDate review on “Attention deficit hyperactivity disorder in children and adolescents: Treatment with medications” (Krull, 2015b) does not mention bupropion, reboxetine, desipramine and nortriptyline as therapeu... |
96020 | PR TEST SELECT & ADMN FUNCTL BRAIN MAP PHYS/QHP | HCPCS | Most of these interventions have not been proven efficacious in blinded randomized controlled trials”. An UpToDate review on “Attention deficit hyperactivity disorder in children and adolescents: Treatment with medications” (Krull, 2015b) does not mention bupropion, reboxetine, desipramine and nortriptyline as therapeu... |
J0600 | Injection, edetate calcium disodium, up to 1000 mg | HCPCS | Most of these interventions have not been proven efficacious in blinded randomized controlled trials”. An UpToDate review on “Attention deficit hyperactivity disorder in children and adolescents: Treatment with medications” (Krull, 2015b) does not mention bupropion, reboxetine, desipramine and nortriptyline as therapeu... |
96902 | PR MCRSCP XM HAIR PLUCK/CLIP FOR CNTS/STRUCT ABNORM | HCPCS | Most of these interventions have not been proven efficacious in blinded randomized controlled trials”. An UpToDate review on “Attention deficit hyperactivity disorder in children and adolescents: Treatment with medications” (Krull, 2015b) does not mention bupropion, reboxetine, desipramine and nortriptyline as therapeu... |
78605 | HC NM BRAIN MINIMUM 4 STATIC VW | HCPCS | Most of these interventions have not been proven efficacious in blinded randomized controlled trials”. An UpToDate review on “Attention deficit hyperactivity disorder in children and adolescents: Treatment with medications” (Krull, 2015b) does not mention bupropion, reboxetine, desipramine and nortriptyline as therapeu... |
70470 | HC CT HEAD/BRAIN W&WO DYE | HCPCS | Most of these interventions have not been proven efficacious in blinded randomized controlled trials”. An UpToDate review on “Attention deficit hyperactivity disorder in children and adolescents: Treatment with medications” (Krull, 2015b) does not mention bupropion, reboxetine, desipramine and nortriptyline as therapeu... |
92568 | PR ACOUSTIC REFLEX THRESHOLD | HCPCS | Most of these interventions have not been proven efficacious in blinded randomized controlled trials”. An UpToDate review on “Attention deficit hyperactivity disorder in children and adolescents: Treatment with medications” (Krull, 2015b) does not mention bupropion, reboxetine, desipramine and nortriptyline as therapeu... |
92548 | PR CDP-SOT 6 CONDITIONS W/INTERPRETATION & REPORT | HCPCS | Most of these interventions have not been proven efficacious in blinded randomized controlled trials”. An UpToDate review on “Attention deficit hyperactivity disorder in children and adolescents: Treatment with medications” (Krull, 2015b) does not mention bupropion, reboxetine, desipramine and nortriptyline as therapeu... |
97532 | ST COGNITIVE SKILLS PER 15 MIN | HCPCS | Most of these interventions have not been proven efficacious in blinded randomized controlled trials”. An UpToDate review on “Attention deficit hyperactivity disorder in children and adolescents: Treatment with medications” (Krull, 2015b) does not mention bupropion, reboxetine, desipramine and nortriptyline as therapeu... |
70555 | Fmri brain by phys/psych | HCPCS | Most of these interventions have not been proven efficacious in blinded randomized controlled trials”. An UpToDate review on “Attention deficit hyperactivity disorder in children and adolescents: Treatment with medications” (Krull, 2015b) does not mention bupropion, reboxetine, desipramine and nortriptyline as therapeu... |
92546 | Sinusoidal rotational test | HCPCS | Most of these interventions have not been proven efficacious in blinded randomized controlled trials”. An UpToDate review on “Attention deficit hyperactivity disorder in children and adolescents: Treatment with medications” (Krull, 2015b) does not mention bupropion, reboxetine, desipramine and nortriptyline as therapeu... |
98942 | PR CHIROPRACTIC MANIPULATIVE TX SPINAL 5 REGIONS | HCPCS | Most of these interventions have not been proven efficacious in blinded randomized controlled trials”. An UpToDate review on “Attention deficit hyperactivity disorder in children and adolescents: Treatment with medications” (Krull, 2015b) does not mention bupropion, reboxetine, desipramine and nortriptyline as therapeu... |
96153 | Intervene hlth/behave group | HCPCS | Most of these interventions have not been proven efficacious in blinded randomized controlled trials”. An UpToDate review on “Attention deficit hyperactivity disorder in children and adolescents: Treatment with medications” (Krull, 2015b) does not mention bupropion, reboxetine, desipramine and nortriptyline as therapeu... |
95816 | PR ELECTROENCEPHALOGRAM W/REC AWAKE&DROWSY | HCPCS | Most of these interventions have not been proven efficacious in blinded randomized controlled trials”. An UpToDate review on “Attention deficit hyperactivity disorder in children and adolescents: Treatment with medications” (Krull, 2015b) does not mention bupropion, reboxetine, desipramine and nortriptyline as therapeu... |
82787 | HC IGG SUBSETS | HCPCS | Most of these interventions have not been proven efficacious in blinded randomized controlled trials”. An UpToDate review on “Attention deficit hyperactivity disorder in children and adolescents: Treatment with medications” (Krull, 2015b) does not mention bupropion, reboxetine, desipramine and nortriptyline as therapeu... |
H1011 | Family assessment | HCPCS | Most of these interventions have not been proven efficacious in blinded randomized controlled trials”. An UpToDate review on “Attention deficit hyperactivity disorder in children and adolescents: Treatment with medications” (Krull, 2015b) does not mention bupropion, reboxetine, desipramine and nortriptyline as therapeu... |
J0470 | Injection, dimercaprol, per 100 mg | HCPCS | Most of these interventions have not been proven efficacious in blinded randomized controlled trials”. An UpToDate review on “Attention deficit hyperactivity disorder in children and adolescents: Treatment with medications” (Krull, 2015b) does not mention bupropion, reboxetine, desipramine and nortriptyline as therapeu... |
90792 | Psychiatric diagnostic evaluation with medical services | HCPCS | Most of these interventions have not been proven efficacious in blinded randomized controlled trials”. An UpToDate review on “Attention deficit hyperactivity disorder in children and adolescents: Treatment with medications” (Krull, 2015b) does not mention bupropion, reboxetine, desipramine and nortriptyline as therapeu... |
92542 | PR POSITIONAL NYSTAGMUS TEST | HCPCS | Most of these interventions have not been proven efficacious in blinded randomized controlled trials”. An UpToDate review on “Attention deficit hyperactivity disorder in children and adolescents: Treatment with medications” (Krull, 2015b) does not mention bupropion, reboxetine, desipramine and nortriptyline as therapeu... |
92538 | PR CALORIC VESTIBULAR TEST W/REC BI MONOTHERMAL | HCPCS | Most of these interventions have not been proven efficacious in blinded randomized controlled trials”. An UpToDate review on “Attention deficit hyperactivity disorder in children and adolescents: Treatment with medications” (Krull, 2015b) does not mention bupropion, reboxetine, desipramine and nortriptyline as therapeu... |
S8035 | MAGNETIC SOURCE IMAGING | HCPCS | Most of these interventions have not been proven efficacious in blinded randomized controlled trials”. An UpToDate review on “Attention deficit hyperactivity disorder in children and adolescents: Treatment with medications” (Krull, 2015b) does not mention bupropion, reboxetine, desipramine and nortriptyline as therapeu... |
92588 | PR DISTRT PROD EVOKD OTOACOUSTIC EMSNS COMP/DX EVAL | HCPCS | Most of these interventions have not been proven efficacious in blinded randomized controlled trials”. An UpToDate review on “Attention deficit hyperactivity disorder in children and adolescents: Treatment with medications” (Krull, 2015b) does not mention bupropion, reboxetine, desipramine and nortriptyline as therapeu... |
95812 | PR ELECTROENCEPHALOGRAM EXTEND MONITORING 41-60 MIN | HCPCS | Most of these interventions have not been proven efficacious in blinded randomized controlled trials”. An UpToDate review on “Attention deficit hyperactivity disorder in children and adolescents: Treatment with medications” (Krull, 2015b) does not mention bupropion, reboxetine, desipramine and nortriptyline as therapeu... |
S9446 | PT education noc group | HCPCS | Most of these interventions have not been proven efficacious in blinded randomized controlled trials”. An UpToDate review on “Attention deficit hyperactivity disorder in children and adolescents: Treatment with medications” (Krull, 2015b) does not mention bupropion, reboxetine, desipramine and nortriptyline as therapeu... |
70496 | HC CTA, HEAD, WITH CONTRAST MATERIAL(S), INCLUDING NONCONTRAST I | HCPCS | Most of these interventions have not been proven efficacious in blinded randomized controlled trials”. An UpToDate review on “Attention deficit hyperactivity disorder in children and adolescents: Treatment with medications” (Krull, 2015b) does not mention bupropion, reboxetine, desipramine and nortriptyline as therapeu... |
70552 | MRI scan of brain with contrast | HCPCS | Most of these interventions have not been proven efficacious in blinded randomized controlled trials”. An UpToDate review on “Attention deficit hyperactivity disorder in children and adolescents: Treatment with medications” (Krull, 2015b) does not mention bupropion, reboxetine, desipramine and nortriptyline as therapeu... |
78601 | HC BRAIN IMAGING, LESS THAN 4 STATIC VIEWS; WITH VASCULAR FLOW | HCPCS | Most of these interventions have not been proven efficacious in blinded randomized controlled trials”. An UpToDate review on “Attention deficit hyperactivity disorder in children and adolescents: Treatment with medications” (Krull, 2015b) does not mention bupropion, reboxetine, desipramine and nortriptyline as therapeu... |
A9583 | Gadofosveset trisodium inj | HCPCS | Most of these interventions have not been proven efficacious in blinded randomized controlled trials”. An UpToDate review on “Attention deficit hyperactivity disorder in children and adolescents: Treatment with medications” (Krull, 2015b) does not mention bupropion, reboxetine, desipramine and nortriptyline as therapeu... |
76390 | HC MR SPECTROSCOPY | HCPCS | Most of these interventions have not been proven efficacious in blinded randomized controlled trials”. An UpToDate review on “Attention deficit hyperactivity disorder in children and adolescents: Treatment with medications” (Krull, 2015b) does not mention bupropion, reboxetine, desipramine and nortriptyline as therapeu... |
97533 | Therapy procedure using sensory experiences | HCPCS | Most of these interventions have not been proven efficacious in blinded randomized controlled trials”. An UpToDate review on “Attention deficit hyperactivity disorder in children and adolescents: Treatment with medications” (Krull, 2015b) does not mention bupropion, reboxetine, desipramine and nortriptyline as therapeu... |
90868 | PR THERAP REPETITIVE TMS TX SUBSEQ DELIVERY & MNG | HCPCS | Most of these interventions have not been proven efficacious in blinded randomized controlled trials”. An UpToDate review on “Attention deficit hyperactivity disorder in children and adolescents: Treatment with medications” (Krull, 2015b) does not mention bupropion, reboxetine, desipramine and nortriptyline as therapeu... |
95928 | PR CTR MOTOR EP STD TRANSCRNL MOTOR STIMJ UPR LIMBS | HCPCS | Most of these interventions have not been proven efficacious in blinded randomized controlled trials”. An UpToDate review on “Attention deficit hyperactivity disorder in children and adolescents: Treatment with medications” (Krull, 2015b) does not mention bupropion, reboxetine, desipramine and nortriptyline as therapeu... |
95803 | PR ACTIGRAPHY TESTING RECORDING ANALYSIS I&R | HCPCS | Most of these interventions have not been proven efficacious in blinded randomized controlled trials”. An UpToDate review on “Attention deficit hyperactivity disorder in children and adolescents: Treatment with medications” (Krull, 2015b) does not mention bupropion, reboxetine, desipramine and nortriptyline as therapeu... |
95926 | Somatosensory testing | HCPCS | Most of these interventions have not been proven efficacious in blinded randomized controlled trials”. An UpToDate review on “Attention deficit hyperactivity disorder in children and adolescents: Treatment with medications” (Krull, 2015b) does not mention bupropion, reboxetine, desipramine and nortriptyline as therapeu... |
92569 | Acoustic Reflex Decay Test | HCPCS | Most of these interventions have not been proven efficacious in blinded randomized controlled trials”. An UpToDate review on “Attention deficit hyperactivity disorder in children and adolescents: Treatment with medications” (Krull, 2015b) does not mention bupropion, reboxetine, desipramine and nortriptyline as therapeu... |
92570 | PR ACOUSTIC IMMIT TEST TYMPANOM/ACOUST REFLX/DECAY | HCPCS | Most of these interventions have not been proven efficacious in blinded randomized controlled trials”. An UpToDate review on “Attention deficit hyperactivity disorder in children and adolescents: Treatment with medications” (Krull, 2015b) does not mention bupropion, reboxetine, desipramine and nortriptyline as therapeu... |
90837 | PSYTX WT PT 60 MINS | HCPCS | Most of these interventions have not been proven efficacious in blinded randomized controlled trials”. An UpToDate review on “Attention deficit hyperactivity disorder in children and adolescents: Treatment with medications” (Krull, 2015b) does not mention bupropion, reboxetine, desipramine and nortriptyline as therapeu... |
95930 | Visual ep test cns w/i&r | HCPCS | Most of these interventions have not been proven efficacious in blinded randomized controlled trials”. An UpToDate review on “Attention deficit hyperactivity disorder in children and adolescents: Treatment with medications” (Krull, 2015b) does not mention bupropion, reboxetine, desipramine and nortriptyline as therapeu... |
98940 | PR CHIROPRACTIC MANIPULATIVE TX SPINAL 1-2 REGIONS | HCPCS | Most of these interventions have not been proven efficacious in blinded randomized controlled trials”. An UpToDate review on “Attention deficit hyperactivity disorder in children and adolescents: Treatment with medications” (Krull, 2015b) does not mention bupropion, reboxetine, desipramine and nortriptyline as therapeu... |
70544 | MRV VENOGRAM W/O | HCPCS | Most of these interventions have not been proven efficacious in blinded randomized controlled trials”. An UpToDate review on “Attention deficit hyperactivity disorder in children and adolescents: Treatment with medications” (Krull, 2015b) does not mention bupropion, reboxetine, desipramine and nortriptyline as therapeu... |
70545 | MRI scan of blood vessels of head with contrast | HCPCS | Most of these interventions have not been proven efficacious in blinded randomized controlled trials”. An UpToDate review on “Attention deficit hyperactivity disorder in children and adolescents: Treatment with medications” (Krull, 2015b) does not mention bupropion, reboxetine, desipramine and nortriptyline as therapeu... |
92558 | PR EVOKED OTOACOUSTIC EMISSIONS SCREEN AUTO ANALYS | HCPCS | Most of these interventions have not been proven efficacious in blinded randomized controlled trials”. An UpToDate review on “Attention deficit hyperactivity disorder in children and adolescents: Treatment with medications” (Krull, 2015b) does not mention bupropion, reboxetine, desipramine and nortriptyline as therapeu... |
90836 | Psytx w pt w e/m 45 min | HCPCS | Most of these interventions have not been proven efficacious in blinded randomized controlled trials”. An UpToDate review on “Attention deficit hyperactivity disorder in children and adolescents: Treatment with medications” (Krull, 2015b) does not mention bupropion, reboxetine, desipramine and nortriptyline as therapeu... |
J3520 | EDETATE DISODIUM POWDER | HCPCS | Most of these interventions have not been proven efficacious in blinded randomized controlled trials”. An UpToDate review on “Attention deficit hyperactivity disorder in children and adolescents: Treatment with medications” (Krull, 2015b) does not mention bupropion, reboxetine, desipramine and nortriptyline as therapeu... |
70551 | MRI scan of brain without contrast | HCPCS | Most of these interventions have not been proven efficacious in blinded randomized controlled trials”. An UpToDate review on “Attention deficit hyperactivity disorder in children and adolescents: Treatment with medications” (Krull, 2015b) does not mention bupropion, reboxetine, desipramine and nortriptyline as therapeu... |
90834 | Psytx w pt 45 minutes | HCPCS | An UpToDate review on “Attention deficit hyperactivity disorder in children and adolescents: Treatment with medications” (Krull, 2015b) does not mention bupropion, reboxetine, desipramine and nortriptyline as therapeutic options. |CPT Codes / HCPCS Codes / ICD-10 Codes|
|Information in the [brackets] below has been add... |
95927 | Somatosensory testing | HCPCS | An UpToDate review on “Attention deficit hyperactivity disorder in children and adolescents: Treatment with medications” (Krull, 2015b) does not mention bupropion, reboxetine, desipramine and nortriptyline as therapeutic options. |CPT Codes / HCPCS Codes / ICD-10 Codes|
|Information in the [brackets] below has been add... |
0333T | Visual ep scr acuity auto | HCPCS | An UpToDate review on “Attention deficit hyperactivity disorder in children and adolescents: Treatment with medications” (Krull, 2015b) does not mention bupropion, reboxetine, desipramine and nortriptyline as therapeutic options. |CPT Codes / HCPCS Codes / ICD-10 Codes|
|Information in the [brackets] below has been add... |
96125 | Test to assess the ability to complete specific functional tasks applicable to environment | HCPCS | An UpToDate review on “Attention deficit hyperactivity disorder in children and adolescents: Treatment with medications” (Krull, 2015b) does not mention bupropion, reboxetine, desipramine and nortriptyline as therapeutic options. |CPT Codes / HCPCS Codes / ICD-10 Codes|
|Information in the [brackets] below has been add... |
92540 | PR VSTBLR FUNCJ NYSTAG FOVL&PERPH STIMJ OSCIL TRK | HCPCS | An UpToDate review on “Attention deficit hyperactivity disorder in children and adolescents: Treatment with medications” (Krull, 2015b) does not mention bupropion, reboxetine, desipramine and nortriptyline as therapeutic options. |CPT Codes / HCPCS Codes / ICD-10 Codes|
|Information in the [brackets] below has been add... |
90875 | PR INDIV PSYCHOPHYS BIOFEED TRAIN W/PSYTX 30 MIN | HCPCS | An UpToDate review on “Attention deficit hyperactivity disorder in children and adolescents: Treatment with medications” (Krull, 2015b) does not mention bupropion, reboxetine, desipramine and nortriptyline as therapeutic options. |CPT Codes / HCPCS Codes / ICD-10 Codes|
|Information in the [brackets] below has been add... |
96101 | Psycho testing by psych/phys | HCPCS | An UpToDate review on “Attention deficit hyperactivity disorder in children and adolescents: Treatment with medications” (Krull, 2015b) does not mention bupropion, reboxetine, desipramine and nortriptyline as therapeutic options. |CPT Codes / HCPCS Codes / ICD-10 Codes|
|Information in the [brackets] below has been add... |
90867 | PR REPET TMS TX INITIAL W/MAP/MOTR THRESHLD/DEL&M | HCPCS | An UpToDate review on “Attention deficit hyperactivity disorder in children and adolescents: Treatment with medications” (Krull, 2015b) does not mention bupropion, reboxetine, desipramine and nortriptyline as therapeutic options. |CPT Codes / HCPCS Codes / ICD-10 Codes|
|Information in the [brackets] below has been add... |
Subsets and Splits
No community queries yet
The top public SQL queries from the community will appear here once available.